SEARCH

SEARCH BY CITATION

References

  • Abolis NG, Araújo SM, Toledo MJO, Fernandez MA & Gomes ML (2011) Trypanosoma cruzi I-III in southern Brazil causing individual and mixed infections in humans, sylvatic reservoirs and triatomines. Acta Tropica 120, 167172.
  • Andrade SG & Magalhães JB (1997) Biodemes and zymodemes of Trypanosoma cruzi strains: correlations with clinical data and experimental pathology. Revista da Sociedade Brasileira de Medicina Tropical 30, 2735.
  • Andrade SG, Magalhães JB & Pontes AL (1985) Evaluation of chemotherapy with benznidazole and nifurtimox in mice infected with Trypanosoma cruzi strains of different types. Bulletin of the World Health Organization 63, 721726.
  • Andrade SG, Rassi A, Magalhães JB, Ferriolli FF & Luquetti AO (1992) Specific chemotherapy of Chagas disease: a comparison between the response in patients and experimental animals inoculated with the same strains. Transactions of the Royal Society of Tropical Medicine and Hygiene 86, 624626.
  • Anonymous (2005) Consenso Brasileiro em Doença de Chagas. Secretaria de Vigilância em Saúde do Ministério da Saúde. Revista da Sociedade Brasileira de Medicina Tropical 38, 130.
  • Brasil (2009) [database on the Internet]. Ministério da Sáude. A Doença de Chagas no Brasil. Available at: http://portal.saude.gov.br/portal/arquivos/pdf/tabchagascasos0509. pdf. Accessed 23 February 2009.
  • Brasil (2012) [database on the Internet]. Ministério da Saúde. Epidemiologia da DCh. Available: http://portal.saude.gov.br/portal/saude/profissional/visualizartexto.cfm?idtext=31454. Accessed 23 February 2012.
  • Brener Z (1962) Therapeutic activity and criterion of cure on mice experimentally infected with Trypanosoma cruzi. Revista do Instituto de Medicina Tropical de São Paulo 4, 389396.
  • Brener Z, Costa CAG & Chiari C (1976) Differences in the susceptibility of Trypanosoma cruzi strains to active chemotherapeutic agents. Revista do Instituto de Medicina Tropical de São Paulo 18, 450455.
  • Brisse S, Barnabé C & Tibayrenc M (2000) Identification of six Trypanosoma cruzi phylogenetic lineages by random amplified polymorphic DNA and multilocus enzyme electrophoresis. International Journal for Parasitology 30, 3544.
  • Caldas S, Santos FM, Lana M et al. (2008) Trypanosoma cruzi: acute and long-term infection in the vertebrate host can modify the response to benznidazole. Experimental Parasitology 118, 315323.
  • Cura CI, Mejia-Jaramillo AM, Duffy T et al. (2010) Trypanosoma cruzi I genotypes in different geographical regions and transmission cycles based on a microsatellite motif of the intergenic spacer of spliced leader genes. International Journal for Parasitology 40, 15991607.
  • Falla A, Herrera C, Fajardo A, Montilla M, Vallejo GA & Guhl F (2009) Haplotype identification within Trypanosoma cruzi I in Colombian isolates from several reservoirs, vectors and humans. Acta Tropica 110, 1521.
  • Filardi LS & Brener Z (1987) Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas disease. Transactions of the Royal Society of Tropical Medicine and Hygiene 81, 755759.
  • Gomes ML, Macedo AM, Vago AR, Pena SD, Galvão LM & Chiari E (1998) Trypanosoma cruzi: optimization of polymerase chain reaction for detection in human blood. Experimental Parasitology 88, 2833.
  • Herrera C, Bargues MD, Fajardo A et al. (2007) Identifying four Trypanosoma cruzi I isolate haplotypes from different geographic regions in Colombia. Infection, Genetics and Evoution 7, 535539.
  • Llewellyn MS, Miles MA, Carrasco HJ et al. (2009) Genome-scale multilocus microsatellite typing of Trypanosoma cruzi discrete typing unit I reveals phylogeographic structure and specific genotypes linked to human infection. PLoS Pathogens 5, e1000410.
  • Marcili A, Valente VC, Valente SA et al. (2009) Trypanosoma cruzi in Brazilian Amazonia: lineages TCI and TCIIa in wild primates, Rhodnius spp. and in humans with Chagas disease associated with oral transmission. International Journal for Parasitology 39, 615623.
  • Miles MA, Toyé PJ, Oswaldo SC & Godfrey DC (1977) The identification by isoenzyme patterns if two distinct strain-groups of Trypanosoma cruzi, circulating independently in a rural area of Brazil. Transactions of the Royal Society of Tropical Medicine and Hygiene 71, 217225.
  • Miyamoto CT, Gomes ML, Marangon AV et al. (2006) Trypanosoma cruzi: sensitivity of the polymerase chain reaction for detecting the parasite in the blood of mice infected with different clonal genotypes. Experimental Parasitology 112, 198201.
  • Miyamoto CT, Gomes ML, Marangon AV et al. (2008) Usefulness of the polymerase chain reaction for monitoring cure of mice infected with different Trypanosoma cruzi clonal genotypes following treatment with benznidazole. Experimental Parasitology 120, 4549.
  • Monteiro WM, Magalhães LKC, Sá ARN et al. (2012) Trypanosoma cruzi IV causing outbreaks of acute Chagas disease and infections by different haplotypes in the Western Brazilian Amazonia. PLoS ONE 7(), e41284. doi:10.1371/journal.pone.0041284.
  • Murta SMF, Gazinelli RT, Brener Z & Romanha AJ (1998) Molecular characterization of susceptible and naturally resistant strains of Trypanosoma cruzi to benznidazole and nifurtimox. Molecular and Biochemical Parasitology 93, 203214.
  • Organización Panamericana de la Salud (OPAS) (2006) Estimación cuantitativa de la enfermedad de Chagas en las Americas Pan American Health Organization (PAHO), Rio de Janeiro, Brazil.
  • Pinto AYN, Ferreira AG, Valente VC, Harada GS & Valente SAS (2009) Urban outbreak of acute Chagas disease in Amazon region of Brazil: four-year follow-up after treatment with benznidazole. Revista Panamericana de Salud Pública 25, 7783.
  • Pinto AYN, Ferreira AG, Valente SAS et al. (2010) Alterações eletrocardiográficas durante e após tratamento com benzonidazol em fase aguda de doença de Chagas autóctone da Amazônia brasileira. Revista Pan-Amazônica de Saúde 1, 6776.
  • Reis D, Monteiro WM, Bossolani GDP et al. (2012) Biological behavior in mice of Trypanosoma cruzi isolates from Amazonas and Paraná, Brazil. Experimental Parasitology 130, 321329.
  • Revollo S, Oury B, Laurent JP et al. (1998) Trypanosoma cruzi: impact of clonal evolution of the parasite on its biological and medical properties. Experimental Parasitology 89, 3039.
  • Romanha AJ, Pereira AAS, Chiari E & Kilgour V (1979) Isoenzyme patterns of cultured Trypanosoma cruzi: changes after prolonged subculture. Comparative Biochemical and Physiology 62, 139142.
  • Santos FR, Pena SDJ & Epplen JT (1993) Genetic and population study of a Y-linked tetranucleotide repeat DNA polymorphism with a simple non-isotopic technique. Human Genetics 90, 655656.
  • Schmunis GA (2007) Epedimiology of Chagas' disease in non-endemic countries: the role of international migration. Memórias do Instituto Oswaldo Cruz 102, 7585.
  • Shaw J, Lainson R & Fraiha H (1969) Considerações sobre a epidemiologia dos primeiros casos autóctones de doença de Chagas registrados em Belém, Pará, Brasil. Revista de Saúde Pública 3, 153157.
  • Spitzner FL, Freitas JM, Macedo AM et al. (2007) Trypanosoma cruzi – triatomine associations and the presence of mixed infections in single triatomine bugs in Paraná state, Brazil. Acta Parasitologica 52, 7481.
  • Tibayrenc M & Ayala FJ (1988) Isozyme variability in Trypanosoma cruzi, the agent of Chagas disease: genetical, taxonomical, and epidemiological significance. Evolution 42, 277292.
  • Toledo MJO, Guilherme ALF, Silva JC et al. (1997) Trypanosoma cruzi: chemotherapy with Benznidazole in mice inoculated with strains from Paraná state and from different endemic areas of Brazil. Revista do Instituto de Medicina Tropical de São Paulo 39, 283290.
  • Toledo MJO, Lana M, Carneiro CM et al. (2002) Impact of Trypanosoma cruzi clonal evolution on its biological properties in mice. Experimental Parasitology 100, 161172.
  • Toledo MJO, Bahia MT, Carneiro CM et al. (2003) Chemotherapy with benznidazole and itraconazole for mice infected with different Trypanosoma cruzi clonal genotypes. Antimicrobial Agents and Chemotherapy 47, 223230.
  • Toledo MJO, Tafuri WL, Bahia MT, Tibayrenc M & Lana M (2004) Genetic diversity and drug resistence in Trypanosoma cruzi, the agent of Chagas disease. Research Advances in Antimicrobial Agents Chemotherapy 4, 1121.
  • Valente SAS, Valente VC, Pinto AYN et al. (2009) Analysis of an acute Chagas disease outbreak in the Brazilian Amazon: human cases, triatomines, reservoir mammals and parasites. Transactions of the Royal Society of Tropical Medicine and Hygiene 103, 291297.
  • Veloso VM, Carneiro CM, Toledo MJ et al. (2001) Variation in susceptibility to benznidazole in isolates derived from Trypanosoma cruzi parental strains. Memórias do Instituto Oswaldo Cruz 96, 10051011.
  • Veloso VM, Romanha AJ, Lana M et al. (2005) Influence of the long-term Trypanosoma cruzi infection in vertebrate host on the genetic and biological diversity of the parasite. Parasitology Research 96, 382389. doi: 10.1007/s00436-005-1373-z.
  • Voller A, Bidwell DE & Bartlett A (1980) Enzyme immunoassays in diagnostic medicine. Theory and practice. Bulletin of the World Health Organization 53, 5565.
  • Wincker P, Britto C, Pereira JB, Cardoso MA, Oelemann W & Morel CM (1994) Use of a simplified polymerase chain reaction procedure to detect Trypanosoma cruzi in blood samples from chronic chagasic patients in a rural endemic area. American Journal of Tropical Medicine and Hygiene 71, 771777.
  • World Health Organization (WHO) (2002) Control of Chagas Disease. Second Report of the WHO Experts Committee, Technical Report Series No. 995. World Health Organization, Geneva.
  • Yun O, Lima MA, Ellman T et al. (2009) Feasibility, drug safety, and effectiveness of etiological treatment programs for Chagas disease in Honduras, Guatemala and Bolivia: 10-year experience of Médecins Sans Frontières. Plos Neglected Tropical Diseases 3, 18.